Parker Vanamee
Kettering University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Parker Vanamee.
The New England Journal of Medicine | 1970
Joseph A. Frascino; Parker Vanamee; P. Peter Rosen
Abstract Renal biopsies performed in seven patients after methoxyflurane anesthesia followed by renal failure disclosed a striking degree of oxalate precipitation. The extent of the precipitation paralleled, but could not fully account for, the corresponding degree of azotemia. Urinary oxalate, determined in six patients, was elevated (96 to 480 mg per 24 hours). Methoxyflurane thus appears to cause secondary hyperoxaluria, and intrarenal oxalate precipitation may occur when renal function is compromised for any reason during or immediately after surgery. Oxalate deposition, when extensive, may contribute to the severity of the renal failure.
Metabolism-clinical and Experimental | 1965
Marian Isaacs; Parker Vanamee
Abstract Fifteen patients with potassium depletion were studied during the development and/or correction of their depletion. Alkalosis occurred in all these subjects. In every instance the alkalosis was associated with a positive cation excess: sodium was retained in excess of chloride in those patients depleted by sodium cycle exchange resins, and chloride was lost in excess of sodium in those patients depleted with diuretics. In every instance correction of the alkalosis was associated with a negative cation excess: chloride was retained in excess of sodium in those patients depleted with diuretics, and sodium was lost in excess of chloride in those patients depleted by sodium cycle exchange resins. Potassium depletion and particularly hypokalemia may be corrected independently of the alkalosis. Chloride is necessary for the correction of metabolic alkalosis only when there has been chloride loss during the development of alkalosis.
Journal of Surgical Research | 1966
Parker Vanamee; Martin Sonenberg; Archie Khentigan; Walter Lawrence; John J. Hudock; Ray Crampton
Summary Secretin was treated with acetic anhydride and the resulting preparation (Sa) was tested in dogs with Thomas duodenal cannulas for its effect on pancreatic flow. Sa caused pancreatic secretion when given as a constant infusion or as a single intravenous injection. A single injection of a large dose of Sa was apparently less stimulatory than a comparable amount of secretin. When a large dose of Sa in the form of a single injection was superimposed on a constant infusion of either secretin or Sa, there was a significant suppression of pancreatic flow. It is postulated that acetylated secretin competes with secretin for receptor sites in the pancreas. The failure to suppress pancreatic flow completely may be related to deacetylation or to residual secretory activity of the acetylated material.
JAMA Internal Medicine | 1956
Parker Vanamee; J. William Poppell; Arvin S. Glicksman; Henry T. Randall; Kathleen E. Roberts
Journal of Clinical Investigation | 1956
Kathleen E. Roberts; J. W. Poppell; Parker Vanamee; Robert Beals; Henry T. Randall
Journal of Applied Physiology | 1956
Kathleen E. Roberts; F. Gregg Thompson; J. William Poppell; Parker Vanamee
The American Journal of Clinical Nutrition | 1965
Ellen Scheiner; Maurice E. Shils; Parker Vanamee
JAMA Internal Medicine | 1975
Sidney J. Winawer; Paul Sherlock; Martin Sonenberg; Parker Vanamee
Annals of Surgery | 1959
Parker Vanamee; Walter Lawrence; Sam Levin; Ann S. Peterson; Henry T. Randall
The New England Journal of Medicine | 1960
Lazaro I. Gidekel; Paul Sherlock; Ann S. Peterson; Parker Vanamee